SAN DIEGO--(BUSINESS WIRE)--Cardium Therapeutics (OTCBB:CDTP) and its operating unit InnerCool Therapies today announced plans to launch two next-generation medical device systems designed to provide innovative and comprehensive solutions to patient temperature modulation. Both new systems are expected to be cleared for market launch within the next two quarters.
